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Background: The developmental cycle of the obligate intracellular pathogen Chlamydia is dependant on the
formation of a unique intracellular niche termed the chlamydial inclusion. The inclusion is a membrane bound
vacuole derived from host cytoplasmic membrane and is modified significantly by the insertion of chlamydial
proteins. A unique property of the inclusion is its propensity for homotypic fusion. The vast majority of cells
infected with multiple chlamydial elementary bodies (EBs) contain only a single mature inclusion. The chlamydial
protein IncA is required for fusion, however the host process involved are uncharacterized.
Results: Here, through live imaging studies, we determined that the nascent inclusions clustered tightly at the cell
microtubule organizing center (MTOC) where they eventually fused to form a single inclusion. We established that
factors involved in trafficking were required for efficient fusion as both disruption of the microtubule network and
inhibition of microtubule trafficking reduced the efficiency of fusion. Additionally, fusion occurred at multiple sites
in the cell and was delayed when the microtubule minus ends were either no longer anchored at a single MTOC
or when a cell possessed multiple MTOCs.
Conclusions: The data presented demonstrates that efficient homotypic fusion requires the inclusions to be in
close proximity and that this proximity is dependent on chlamydial microtubule trafficking to the minus ends of
microtubules.
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Chlamydia trachomatis causes sexually transmitted infec-
tions and is the leading cause of preventable blindness
worldwide [1]. Chlamydia are Gram-negative, obligate
intracellular bacteria with a unique, biphasic developmen-
tal cycle that takes place in a membrane-bound vacuole
termed the inclusion. The infectious but metabolically in-
active elementary body (EB) attaches to epithelial cells and
initiates its uptake through parasite mediated endocytosis
[2]. Once internalized, EBs differentiate into metabolically
active but non-infectious reticulate bodies (RBs) which
replicate by binary fission. As the infection progresses,
RBs differentiate into EBs in an asynchronous manner and
these infectious EBs are eventually released into the host
to initiate a additional rounds of infection.
Following infection, the inclusion membrane is modified
through the insertion of multiple bacterial type three* Correspondence: sgriesha@ufl.edu
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reproduction in any medium, provided the orsecreted effector proteins [3]. These inclusions are non-
fusogenic with the endosomal and lysosomal pathways [4].
Inclusions are trafficked along microtubules in a dynein-
dependent manner to the microtubule organizing center
(MTOC) where they intercept host-derived lipids to main-
tain the integrity of the expanding inclusion [5]. Thus,
despite being sequestered within a membrane-bound
vacuole, chlamydiae manipulate the host and subvert host
pathways to establish an environment that is not only con-
ducive to replication and differentiation but also simultan-
eously protected from host immune responses.
At high multiplicities of infection, multiple inclusions
fuse into a single inclusion. This fusion event is critical for
pathogenicity; rare isolates with non-fusogenic inclusions
are clinically associated with less severe signs of infection
and lower numbers of recoverable bacteria than wild-type
isolates [6]. Inclusion fusion occurs even between different
C. trachomatis serovars potentially facilitating genetic ex-
change between serovars [7]. Previous studies have dem-
onstrated that the fusion of chlamydial inclusions requiresl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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at 32°C [8]. Specifically, the inclusion membrane protein
IncA is required for the homotypic fusion of chlamydial
inclusions [9].
The importance of both inclusion trafficking and inclu-
sion fusion have been established but the role that inclu-
sion trafficking plays in promoting fusion has not been
investigated. In this study we demonstrate that inclusion
migration along microtubules promotes inclusion fusion.
Interestingly, although this dynein dependent migration
was required for the normal timing of inclusion fusion, in-
hibition of this trafficking was eventually overcome later
during infection.
Methods
Organisms and cell culture
All cells were obtained from the American Type Culture Col-
lection. Cell lines are: McCoy (McCoy B, CRL-1696), HeLa
(HeLa 229, CCL-2.1), Cos7 (COS-7, CRL-1651) and neuro-
blastoma (N1E-115, CRL-2263). Chlamydia trachomatis
serovars are: L2 (LGV 434), G (UW-524/CX) and J (UW-
36/CX). C. trachomatis were propagated in McCoy or HeLa
cells. EBs were purified by Renografin (Bristol-Myers Squibb,
New York, NY, USA) density gradient centrifugation as pre-
viously described [10,11]. HeLa and Cos7 cells were grown
in RPMI-1640 (Lonza, Basel, Switzerland) supplemented
with 10% FBS (Gibco/Life Technologies, Grand Island, NY,
USA) and 10 μg/mL gentamicin (Gibco). McCoy and
neuroblastoma cells were grown in DMEM (Lonza)
supplemented with 10% FBS (Gibco) and 10 μg/mL genta-
micin (Gibco). All cells were grown in 5% CO2 at 37°C.
Infections
All infections were carried out as follows unless otherwise
noted. Cells were incubated with C. trachomatis EBs in
Hank’s balanced salt solution (HBSS) (Invitrogen/Life
Technologies, Grand Island, NY, USA) for 30 min at 22°C.
The inoculum was replaced with prewarmed, 37°C, com-
plete media. For nocodazole treated cells, the inoculum
was replaced with prewarmed, 37°C, complete media
containing 5 μg/mL nocodazole. Infected cells were incu-
bated in 5% CO2 at 37°C.
Synchronized infections
Cells were incubated with C. trachomatis EBs in HBSS
(Invitrogen) at MOI = 1000 for 5 min at 22°C. The cells
were washed three times with HBSS plus 100 μg/mL hep-
arin (Pharmacia, Peapack, NJ, USA) and twice with HBSS
without heparin. Prewarmed, 37°C, complete media was
added and infected cells were incubated in 5% CO2 at 37°C.
Transfections and plasmids
HeLa cells were grown on 12 mm number 1.5 borosili-
cate glass coverslips coated with Poly-L-lysine (Sigma-Aldrich, St. Louis, MO, USA) to obtain a monolayer of
approximately 65% confluency. Transfections were car-
ried out using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. Expression from the
transfected vectors was allowed to proceed for at least
24 h prior to experimentation. Expression vectors used
were pEGFP-C3 (Clontech, Mountain View, CA, USA),
EB1-GFP and EB1.84-GFP. The EB1-GFP plasmid was a
kind gift from Dr Jennifer S. Tirnauer, University of
Connecticut Health Center. The EB1.84-GFP plasmid was
generated by PCR cloning of the N terminal end of EB1
and cloning into pDest-NGFP as described by Askham
et al. [12].
Micro-injections
Cos7 cells were grown on 25 mm number 1.5 borosilicate
glass coverslips coated with Poly-L-lysine (Sigma-Aldrich)
to obtain a monolayer of approximately 50% confluency.
Micro-injection was performed using an automated sys-
tem described previously [5]. Cells were injected with
either mouse monoclonal antibody to dic74.1 (Covance,
Princeton, NJ, USA) or antiCD80 (Invitrogen). Following
injection, cells were washed once with prewarmed, 37°C,
complete media, and fresh prewarmed media was added.
Approximately 10–15 min after injection, the cells were
infected with C. trachomatis and incubated in 5% CO2 at
37°C. The cells were fixed with 4% paraformaldehyde and
permeabilized with 0.5% TritonX 100. The injected anti-
bodies were detected using AlexaFluor 488-conjugated
goat anti-mouse IgG (Molecular Probes/Life Technologies,
Grand Island, NY, USA).
Antibodies and microscopy
For fluorescent antibody staining, infected cells were
fixed with cold methanol for 10 min. Antibodies used
in these experiments were mouse monoclonal anti-
γ-tubulin (Sigma-Aldrich), anti-chlamydial inclusion
membrane protein IncA a gift from Dr. Dan Rockey,
at the Oregon State University, and anti-chlamydial
MOMP a gift from Dr. Harlan Caldwell, Rocky Moun-
tain Labs NIAID. C. trachomatis was stained with hu-
man serum (Sigma-Aldrich) unless otherwise noted. To
visualize the primary antibodies, cells were incubated
with the appropriate AlexaFluor conjugated secondary
antibody: 488, 567 or 647 against mouse, rabbit or
human IgG (Molecular Probes). To visualize DNA, cells
were stained with the far-red fluorescent dye DRAQ5
(Biostatus Limited, Leicestershire, UK). Images were
acquired using a spinning disk confocal system connected
to a Leica DMIRB microscope with a 63× oil-immersion
objective, equipped with a Photometrics cascade-cooled
EMCCD camera, under the control of the Open Source
software package μManager (http://www.micro-manager.
org/). Images were processed using the image analysis
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were constructed using the ImageJ image software
(Wayne Rasband, U.S. National Institutes of Health,
http://rsb.info.nih.gov/ij).
Results
Inclusion fusion occurs at the MTOC
The location and dynamics of inclusion fusion are cur-
rently poorly understood. To determine the subcellular
location of fusion in multiply infected cells, HeLa cells
were transfected with EB1-GFP. EB1 is a microtubule
end plus end tracking protein and serves to identify
the site of the microtubule organizing center (MTOC).
Eighteen hours post-transfection, cells were infected
with C. trachomatis at MOI ~20. Infected cells were
imaged every 10 minutes for a total of 24 hours. Repre-
sentative time points (Figure 1) revealed that early dur-
ing infection, multiple inclusions were present adjacent
to cell centrosomes (Figure 1, 8:50–11:30 hpi). As the
infection proceeded, fusion occurred between closely
grouped inclusions (Figure 1, 11:30–12:30 hpi). Fusion
continued until there was a single inclusion (Figure 1,
12:30 hpi) which continued to expand as the develop-
mental cycle progressed (Figure 1, compare 12:30 and
15:50 hpi). In these experiments, fusion was only ob-
served between inclusions tightly clustered around the
MTOC/centrosome of the host cell. (Also see Additional
file 1: Movie 1).Figure 1 Inclusion fusion occurs at the centrosomes. HeLa cells
were transfected with EB1-GFP to visualize centrosomes (arrow in A).
Eighteen hours post-transfection, cells were infected with C.
trachomatis at MOI = 20. During infection, cells were photographed
every 10 minutes until 24 hpi. Times post infection are indicated in
each corresponding image.Intact microtubules are required for efficient inclusion
fusion
We demonstrated that fusion occurs at the centrosomes
and we have previously reported that trafficking on mi-
crotubules is required for the localization of chlamydial
inclusions at the centrosomes. We asked whether the
microtubule network influenced inclusion fusion. HeLa
cells were infected with C. trachomatis. Following infec-
tion, cells were incubated in the presence or absence of
nocodazole and then fixed every two hours between 10
and 24 hpi. Inclusion fusion occurred at approximately
14 hpi for untreated cells (Figure 2A). In cells that had
been treated with nocodazole, fusion was significantly
delayed. Nocodazole-treated cells had an average of eight
inclusions per cell at 24 hpi (Figure 2A). Fusion was not
completely abolished by nocodazole treatment suggesting
that the fusion machinery does not require microtubules
but instead that the microtubules accelerate fusion. Repre-
sentative pictures of nocodazole treated and untreated
cells are shown in Figure 2B and C, respectively.
Inhibiting dynein function in HeLa cells inhibits inclusion
fusion
Chlamydial microtubule trafficking is dependent on the
host microtubule motor protein dynein. To investigateFigure 2 Inclusion fusion is delayed in HeLa cells treated with
nocodazole. HeLa cells were infected with C. trachomatis at MOI ~
9 in the presence and absence of nocodazole (Noc) and fixed at
10, 12, 14, 16, 20, 22 and 24 hpi. Cells were stained with human
sera and anti-g-tubulin antibodies and inclusions were enumerated
(A). Representative treated and untreated HeLa cells (B and C,
respectively).
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cells with anti-dynein intermediate chain antibodies
(DIC74.1). Following injection, cells were infected with
C. trachomatis. Uninjected cells were infected in parallel.
Cells were fixed at 6 and 24 hpi. In cells that had been
injected with anti-dynein antibodies, inclusion clustering
was decreased early in infection and inclusion fusion
decreased (Figure 3A and B, respectively). At 24 hpi,
there was a significant difference between injected and
uninjected cells (P < 0.001); injected cells averaged three
inclusions per infected cell while uninjected cells aver-
aged one inclusion per infected cell (Figure 3C).
Fusion is delayed in neuroblastoma cells
We established that inclusion fusion occurs at cell centro-
somes and both dynein and microtubules promote fusion.
We next asked whether infection of cells with multiple
centrosomes would lead to multiple sites of fusion. The
mouse neuroblastoma cell line N115 has significant cen-
trosome number defects containing an average of eight
centrosomes per cell [13,14]. This allowed us to ask whe-
ther defects in centrosome numbers would affect inclu-
sion fusion. HeLa and neuroblastoma cells were infected
with C. trachomatis at three different multiplicities of
infection. Infections were fixed at 3 hpi and every two
hours between 10 and 24 hpi. Early inclusions were present
near the tightly clustered centrosomes in HeLa cells but in
neuroblastoma cells, which have multiple centrosomes dis-
tributed throughout the cell, early inclusions were present
throughout the host cytosol clustered at the scattered
centrosomes (Figure 4A 3 hpi and 4B 3 hpi, respectively).
At 24 hpi, infected HeLa cells had a single inclusion adja-
cent to the centrosomes (Figure 4 24 hpi). While some
infected neuroblastoma cells had single inclusions atFigure 3 Chlamydial inclusion trafficking and fusion is dynein depend
micro-injection with anti-dynein antibodies. Uninjected cells were infected in
with human sera (red) and the appropriate secondary for the anti-dynein anti
24 hpi (A and B, respectively). Inclusions per infected cell were enumerated f24 hpi, infected neuroblastoma cells could still be found
with multiple unfused inclusions (Figure 4B 24 hpi). In
infected HeLa cells, fusion of chlamydial inclusions
occurred at approximately 12-14 hpi (Figure 4C). Fusion
was delayed in neuroblastoma cells, occurring at appro-
ximately 16-18 hpi (Figure 4D).
Neuroblastoma cells are fusion competent and inclusion
membrane protein IncA is present on their inclusion
membranes
In order to determine whether neuroblastomas were fu-
sion competent, HeLa and neuroblastoma cells were seri-
ally infected with different C. trachomatis serovars. Cells
were infected with C. trachomatis serovar G for 40 hours
and then superinfected with C. trachomatis serovar L2 for
four hours. In both HeLa cells and neuroblastomas, fusion
occurred between inclusions containing G and L2 indicat-
ing that the inclusions in neuroblastoma cells are fusion
competent (Figure 5A and 5B). The inclusion membrane
protein IncA is required for inclusion fusion and delays in
IncA membrane localization lead to delayed homotypic
fusion [8,9,15]. Therefore, we assessed the location of
IncA in the infected neuroblastoma cells. HeLa and
neuroblastoma cells were infected with C. trachomatis
serovar L2, fixed at 24 hpi and stained with antibodies
to IncA. IncA was present on inclusion membranes in
both HeLa and neuroblastoma cells (Figure 5C and 5D,
respectively). Taken together, these data demonstrate that
the delay in inclusion fusion observed in neuroblastoma
cells is not due to differences in fusion competency or
to differences in the presence of IncA. Additionally, when
infected neuroblastomas were grown on fibronectin
micropatterns to force centrosome clustering, inclusion
fusion was restored (Additional file 2: Figure S1).ent. Cos7 cells were infected with C. trachomatis serovar L2 following
parallel. Twenty-four hours postinfection, cells were fixed and stained
body (green). Representative picture of anti-dynein injected cells at 6 and
or injected and uninjected cells at 24 hpi, P < 0.0001 (C).
Figure 4 Inclusion fusion is delayed in cells with multiple unclustered centrosomes. HeLa cells (A) and neuroblastomas (B) were infected
with C. trachomatis at MOI ~ 27 and fixed at 3 and 24 hpi. Cells were stained with anti-g-tubulin antibodies (green) and human sera (red). HeLa
cells (C) and neuroblastomas (D) were infected with C. trachomatis at MOI ~ 3, 9 and 27 and fixed at 10, 12, 14, 16, 20, 22 and 24 hpi. Cells were
stained with human sera and inclusions were enumerated.
Figure 5 Neuroblastomas are fusion competent and IncA
localizes to the inclusion membrane during infection. HeLa cells
(A) and neuroblastomas (B) were infected with C. trachomatis
serovar G. At 40 hpi, cells were superinfected with C. trachomatis
serovar L2 and fixed four hours after superinfection. Cells were
stained with human sera (red) and anti-L2 MOMP antibodies (green).
HeLa cells (C) and neuroblastomas (D) were infected with C.
trachomatis serovar L2 at MOI ~ 9 and fixed 24 hpi. Cells were
stained with human sera (blue) and anti-IncA antibodies (green).
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minus ends
Chlamydial inclusion fusion occurs at host centrosomes
and is delayed when extra centrosomes are present. Inclu-
sion migration is unidirectional resulting in the chlamydial
inclusion residing at the cell centrosome for its entire
intracellular growth phase. In the cell, the centrosome acts
as the organizing center that anchors the majority of
microtubule minus ends. We hypothesize that inclusion
fusion is promoted by inclusion crowding at the anchored
minus ends of microtubules. To determine if fusion is
dependent on microtubule minus end anchoring, we
transfected HeLa cells with the GFP tagged EB1 mutant,
EB1.84-GFP. Cells expressing EB1.84-GFP have defects in
microtubule organization and centrosomal anchoring
resulting in unanchored free microtubule minus ends
[12]. When we compared inclusion fusion in the cells that
had been mock transfected to cells transfected with
EB1.84-GFP, the EB1.84 producing cells were markedly
delayed in inclusion fusion. At 24 hpi, transfected cells
averaged 1.7 inclusions per infected cell while mock
transfected cells averaged one inclusion per infected cell
(P < 0.001). We also quantitated the distribution of in-
clusion numbers in these cells, slightly under half of the
cells transfected with EB1.84-GFP contained one inclusion
(46%) while the majority of mock transfected cells (92%)
had a single inclusion (Figure 6A and B, respectively).
Additionally, many of the EB1.85 transfected cells had
Figure 6 Transfection with EB1.84-GFP disrupts inclusion
fusion. HeLa cells were transfected with EB1.84-GFP or mock
transfected. They were then infected with C. trachomatis. Twenty-
four hours postinfection, cells were fixed and stained with human
sera and inclusions per infected cell were enumerated. The
distribution in the number of inclusions per infected cell is shown
for the EB1.84-GFP transfected and mock transfected cells in A and
B, respectively. Mock transfected cells were also stained with anti-g-
tubulin antibodies (green). Representative transfected and mock
transfected cells shown in C and D, respectively.
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cells never had more than two inclusion per cell (Figure 6A
and B, respectively). Representative images of inclusions
in transfected and mock transfected cells are shown in
Figure 6C and D, respectively.
Discussion and conclusion
The ability of C. trachomatis inclusions to fuse is critical to
pathogenicity. Compared to wild type strains, rare isolates
with non-fusogenic inclusions are clinically associated with
less severe signs of infection and lower numbers of reco-
verable bacteria [6]. In cell culture however, a role for
inclusion fusion has yet to be determined. Matched pairs
of non-fusing and fusing strains as well as nocodazole
treated and untreated matched sets grow at similar rates
and produce comparable numbers of progeny [16,17].
Chlamydial inclusion fusion is however critical to patho-
genicity though the exact reason for this remains elusive.
Homotypic inclusion fusion in C. trachomatis is a pheno-
type shared by all serovars. Considering that the meta-
bolically active form of this obligate intracellular organism
is spatially sequestered, it is plausible that sharing a single
inclusoplasm facilitates genetic and/or nutrient exchange
between between co-infecting trachomatis serovars thus
promoting their fitness within a population. It is well
established that C. trachomatis stores sugars in the form
of glycogen in the inclusion [18,19] and this glycogenstorage is linked to virulence as loss of the chlamydial
cryptic plasmid results in both loss of glycogen storage as
well as reduced virulence [20]. Homotypic inclusion
fusion would allow this resource to be shared by bacteria
and may lead to a competitive growth advantage in a hos-
tile environment such as the reproductive track during
in vivo infection.
A complete understanding of mechanisms and factors
required for homotypic fusion is currently unknown. The
chlamydial inclusion membrane protein IncA is the only
chlamydial factor known to be required for homotypic
inclusion fusion [9,21]. Additionally, no host factors have
been identified to be required for homotypic fusion.
Here, we describe a novel role for proper inclusion tra-
fficking in inclusion fusion. Through live cell imaging
studies, we showed that inclusion fusion occurs predom-
inantly at a single site within host cells. This site was in-
variably the MTOC of the cell (Figure 1 and Additional
file 1). Early in infection, multiple inclusions cluster tightly
at the MTOC and remain associated as these inclusions
begin to fuse. After fusion is complete, the single inclusion
retains its close association with the MTOC as it con-
tinues to expand.
The MTOC contains the cells centrosomes and acts as
an organizing foci for the cell. Additionally, the MTOC
acts as the nucleation point for cellular microtubules.
Host microtubules are polymerized in a polar fashion;
the plus ends undergo rapid polymerization while the
minus ends are anchored at the MTOC which allows for
directional transport along the microtubules. We pre-
viously demonstrated that the the nascent chlamydial in-
clusion trafficks along microtubules using the microtubule
motor protein dynein [5]. This study demonstrates that
inclusion migration is a critical component for efficient fu-
sion as both the dynein motor protein and intact microtu-
bules are important for inclusion fusion. The requirement
for both an intact microtubule network and the dynein
motor protein along with the observation that fusion takes
place between closely adjacent inclusions suggests that
migration to a central location in the cell is a mechanism
to physically drive the inclusions together. This increases
the likelihood that the fusogenic protein IncA on neigh-
boring inclusions will interact, thereby enhancing a timely
fusion. This hypothesis is further supported by the obser-
vation that when the minus ends of the microtubules are
not anchored (EB1.84 expressing cells) or not anchored
at a single site in the cell (neuroblastomas), fusion was
severely delayed. Interestingly, in neuroblastoma cells, the
non fused inclusions appear to be in close proximity to
each other however the resolution of fluorescence micros-
copy cannot resolve molecular level interactions. This
suggests that for the chlamydial fusion protein IncA to
interact with an IncA protein on a second inclusion, the
distance between them would likely need to be very small.
Richards et al. BMC Microbiology 2013, 13:185 Page 7 of 7
http://www.biomedcentral.com/1471-2180/13/185Interestingly, fusion is only delayed under these circum-
stances suggesting that eventually multiple inclusions in
the cell come in close enough contact for the IncA driven
fusion system to mediate fusion.
Overall our data support a model where nascent
chlamydia-containing inclusions traffic along microtu-
bules using the dynein motor protein to directionally
traffic to the minus ends of microtubules. If the minus
ends of the microtubules are anchored at the MTOC,
then the multiple inclusions make close contact and are
spatially arranged to encourage fusion. Interestingly, this
trafficking takes place prior to IncA expression. Inclusion
migration is rapid and occurs within the first few hours of
infection however IncA is only expressed during the mid
cycle of chlamydial infection, about 8 hours after infection
[22]. The inclusions are maintained in a fusion-supporting
organization until fusion is initiated through IncA protein
expression and insertion into the inclusion membrane.
This suggests a stepwise pathway of establishing the
mature, fusion-competent chlamydial inclusion.
We have shown that inclusion fusion occurs at host cell
centrosomes and that in order for fusion to result in a sin-
gle inclusion, nascent inclusions must be transported by
dynein along intact, anchored microtubules to a single
site. Comprehending the role of microtubule trafficking in
inclusion fusion dynamics is crucial to a complete under-
standing of the mechanisms by which this obligate intra-
cellular pathogen promotes its intracellular survival and
pathogenicity.
Additional files
Additional file 1: Inclusion fusion occurs at minus ends of
microtubules. Movie of Figure 1.
Additional file 2: Figure 2. Centrosome positioning affects chlamydial
inclusion localization. Uninfected and infected neuroblastomas were
plated on CYTOOchips (glass coverslips imprinted with fibronectin
micropatterns). Each micropattern is indicated in the lower left of the top
panel. Infected cells were fixed at 12 and 24 hpi (top and bottom panel
for each shape, respectively). Cells were stained with antibodies to g-
tubulin (green) and Chlamydia (red). Nucleic acid is visualized by staining
with DRAQ5 (blue).
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